The identification of unique Marek's disease (MD) virus (MDV) antigens expressed not only in lytically infected cells but also in latently infected MD lymphoblastoid tumor cell lines is important in understanding the molecular mechanisms of latency and transformation by MDV, an oncogenic lymphotropic herpesvirus of chickens. Through cDNA and nucleotide sequence analysis, an open reading frame (designated the pp38 ORF) which encodes a predicted polypeptide of 290 amino acids was identified in BamHI-H. Demonstration that the pp38 ORF spans the junction of the MDV long unique and long internal repeat regions (MDV has an alphaherpesvirus genome structure) precludes the presence of the gene encoding the B-antigen complex (gplOO, gp6O, and gp49) in the same region of BamHI-H, where it was originally thought to exist. Duplication of the complete pp38 ORF was not observed in BamHI-D, but part of it (encoding 45 amino acids) was found in the long terminal repeat region of the fragment. By use of tipE-pp38 fusion proteins, antisera against pp38 we-re prepared. By immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a predominant virus-specific 38,000-dalton polypeptide (designated pp38) and a minor 24,000-dalton polypeptide (designated p24) were found. No precursor-product relationship was found between pp38 and p24 by pulse-chase analysis, and only pp38 was detected by Western blot (immunoblot) analysis with antiserum to pp38. pp38 was found to be phosphorylated and present in oncogenic serotype 1-but not nononcogenic serotype 3-infected cells. Expression of the gene encoding pp38 was relatively insensitive to phosphonoacetic-acid inhibition, suggesting that pp38 may belong to one of the early classes of herpesvirus proteins. pp38 was also detected in the latently infected MSB-1 lymphoblastoid tumor cell line. The detection of antibody against pp38 in immune chicken sera indicates that pp38 is an immunogen in birds with MD. Most of the properties described here for a protein detected by methods based on finding the ORF first are identical to those of a 38-kDa phosphoprotein reported by others, suggesting that they are the same. Collectively, the data reported here provide (i) more definitive information on the complete ORF of another MDV gene and the protein that it encodes, (ii) clarification of the gene content within a specific region of the MDV genome, and (iii) the molecular means to conduct further studies to determine whether pp38 plays a role in MDV latency and transformation.
The identification of unique Marek's disease (MD) virus (MDV) antigens expressed not only in lytically infected cells but also in latently infected MD lymphoblastoid tumor cell lines is important in understanding the molecular mechanisms of latency and transformation by MDV, an oncogenic lymphotropic herpesvirus of chickens. Through cDNA and nucleotide sequence analysis, an open reading frame (designated the pp38 ORF) which encodes a predicted polypeptide of 290 amino acids was identified in BamHI-H. Demonstration that the pp38 ORF spans the junction of the MDV long unique and long internal repeat regions (MDV has an alphaherpesvirus genome structure) precludes the presence of the gene encoding the B-antigen complex (gplOO, gp6O, and gp49) in the same region of BamHI-H, where it was originally thought to exist. Duplication of the complete pp38 ORF was not observed in BamHI-D, but part of it (encoding 45 amino acids) was found in the long terminal repeat region of the fragment. By use of tipE-pp38 fusion proteins, antisera against pp38 we-re prepared. By immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a predominant virus-specific 38,000-dalton polypeptide (designated pp38) and a minor 24,000-dalton polypeptide (designated p24) were found. No precursor-product relationship was found between pp38 and p24 by pulse-chase analysis, and only pp38 was detected by Western blot (immunoblot) analysis with antiserum to pp38. pp38 was found to be phosphorylated and present in oncogenic serotype 1-but not nononcogenic serotype 3-infected cells. Expression of the gene encoding pp38 was relatively insensitive to phosphonoacetic-acid inhibition, suggesting that pp38 may belong to one of the early classes of herpesvirus proteins. pp38 was also detected in the latently infected MSB-1 lymphoblastoid tumor cell line. The detection of antibody against pp38 in immune chicken sera indicates that pp38 is an immunogen in birds with MD. Most of the properties described here for a protein detected by methods based on finding the ORF first are identical to those of a 38-kDa phosphoprotein reported by others, suggesting that they are the same. Collectively, the data reported here provide (i) more definitive information on the complete ORF of another MDV gene and the protein that it encodes, (ii) clarification of the gene content within a specific region of the MDV genome, and (iii) the molecular means to conduct further studies to determine whether pp38 plays a role in MDV latency and transformation.
Marek's disease (MD) is a lymphoproliferative disease of chickens caused by cell-associated MD virus (MDV) and is characterized principally by T-cell lymphomas and peripheral nerve demyelination (4, 25) . T-cell lymphomas occur after the establishment of latency in MDV-infected chickens, raising questions regarding the viral gene(s) expressed to cause these two phenomena. Presumably one or more viral genes are responsible for the establishment and maintenance of latency and for tumor induction. Whether these events are the result of the same gene or separate genes is unknown.
Identification of an MDV-specific antigen(s) expressed not only in MDV-infected fibroblast cells but also in latently infected and transformed MD lymphoblastoid tumor cell lines and MD tumors is an important first step toward an understanding of the mechanisms of latency and transformation by MDV.
In lytically infected cells, there is extensive gene expression over the entire MDV genome (19, 29) . In latently infected lymphoblastoid tumor cell lines derived from MD tumors, 4 to 7 transcripts were reported by Schat et al. (29) in their partial transcriptional mapping of MDV, 32 transcripts clustered in the short and long repeat regions were reported by Sugaya et al. (33) , and 29 transcripts spread over almost the entire MDV genome were reported by Maray et al. (19) . Very few of the transcripts detectable in both lytically and latently infected cells were further characterized. Relevent to this study was the report of a 1.9-kb immediate-early (IE) transcript localized to BamHI-H (29) . Silva RNA isolation and Northern (RNA) blot analysis. Total cellular RNA was isolated from mock-and MDV-infected DEF cells essentially as described previously (5) . Purification of poly(A)+ RNA was carried out as described previously (27) . RNA was size fractionated on a 1.2% agarose gel containing 2.2 M formaldehyde and was transferred to a nitrocellulose filter. The Northern blot was hybridized (probes are described in figure legends) and washed as described previously (5) . Transcript size determinations were based on a comparison with a BRL RNA ladder run in parallel.
Si nuclease analysis. S1 nuclease analysis was carried out essentially as described previously (27) with the probes described in the text. The radiolabeled DNAs from a DNA sequencing reaction were used as size markers. Hybridizations were performed at 46°C, a temperature chosen because of the G+C contents of the MDV DNA probes.
Expression of trpE fusion proteins. The vector system used to express the MDV ORF in E. coli consists of a group of plasmids (pATH vectors) encoding approximately 37 kDa of the bacterial trpE ORF under the control of the inducible trp operon promoter (17) . A polylinker with multiple cloning sites at the 3' end of the trpE ORF allows in-frame insertion of a foreign ORF. Five DNA fragments from the MDV ORF were inserted into various trpE pATH vectors, and their respective trpE fusion proteins were generated. The precise locations of these DNA fragments and the sizes of their respective trpE fusion proteins are detailed in Results.
Antibody production. Fusion proteins were purified by electrophoresis in preparative 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gels. The gels were stained with Coomassie brilliant blue to identify the positions of the fusion proteins. (23) or 2 ,ug of tunicamycin (Calbiochem-Behring Corp.) per ml, cells were preincubated with PAA for 24 h or with tunicamycin for 1 h and treated at the same concentration during the 4-h labeling period. After labeling was complete, the culture medium was collected, the cells were washed three times with sterile phosphatebuffered saline, and ice-cold detergent buffer was added to lyse the cells (10) . The culture medium samples and lysates were clarified by centrifugation as previously reported (10) .
Immunoprecipitation and SDS-PAGE analyses. Immunoprecipitation analysis was carried out as previously described (10) . The immunoprecipitates were washed, suspended in sample buffer, and analyzed .by SDS-polyacrylamide gel electrophoresis (PAGE). Protein markers (BRL) were used as molecular weight standards. Molecular sizes were calculated by interpolation between standard proteins by the method of Weber and Osborn (34) . Fluorography was carried out as previously described (2). Ten percent SDSpolyacrylamide gels were used unless indicated otherwise.
Anti-pp38, an antiserui-i 4gainst one of the trpE fusion proteins of the MDV ORF, was used unless indicated otherwise.
Western blot (immunoblot) analysis. Western blot analysis was carried out essentially as described previously (27) .
358-labeled infected-cell lysates were, used for immunoprecipitation analysis with anti-pp38, and the immunoprecipitates were run on a 10% SDS-polyacrylamide gel. Proteins were blotted onto a nitrocellulose filter. The filter was probed with anti-pp38 at a 1:400 dilution. Horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Sigma) was used as the second antibody. Bound second antibody was detected by subsequent incubation in the presence of the substrate solution (4-chloro-1-naphthol) (Sigma).
Nucleotide sequence accession number. The nucleotide sequence reported in this article has been given GenBank accession number M73484. (Fig. 1E) .
RESULTS
Detection of the transcript for cDNA 2. Since cDNA 7 is a part of cDNA 2, only the latter was used as a probe for Northern blot analysis. A major 1.95-kb transcript was detected along with two minor components at 1.3 and 0.8 kb ( Fig. 2A ; data from a long exposure are presented to demonstrate the existence of the latter two). When the EcoRI c subfragment was used as a probe (Fig. 1B) , only the 1.95-kb mRNA was detected ( exposure (data not shown). Since 525 bp of cDNA 2 is located in the EcoRI c subfragment (Fig. 1D) and only the 1.95-kb mRNA was detected by both probes (cDNA 2 and EcoRI c subfragment), the 1.95-kb major transcript (Fig. 1E) is the mRNA from which cDNA 2 is generated.
Defining the 5' end of the 1.95-kb mRNA by S1 nuclease analysis. On the basis of the location of 1,092-bp cDNA 2 ( Fig. 1D ) and the size (1.95 kb) of the major transcript, the 5' end of the mRNA was predicted to be located adjacent to an (Fig. 4 ): a C in cDNA 2 compared with an A in the genomic DNA at position 1,045, the third position of a codon within a predicted ORF, resulting in no predicted amino acid change; and a T in cDNA 2 compared with a C in the genomic DNA at position 1,516, which is in the 3' noncoding region of a predicted ORF.
Analysis of the DNA sequences of cDNA 2 and BamHI-H (Fig. 4) resulted in identification of an ORF, designated pp38 ORF (Fig. 1F ), which encodes a predicted polypeptide of 290 amino acids. The first in-frame ATG initiation codon of the pp38 ORF is located just 3 nucleotides upstream of EcoRI site 1 (Fig. 4) . A 367-base 5' untranslated leader sequence and a 617-base 3' untranslated sequence were found in the 1.95-kb mRNA (Fig. 4) . A potential TATA consensus sequence is located 38 bp upstream of the mRNA initiation site (Fig. 4 ). An AATAAA motif for polyadenylation was found at position 1,836, 13 bp before the start of the poly(A) tail in cDNA 2 (Fig. 4) ; this position is within the general range of 10 to 30 bases upstream of the 3' end before the addition of the poly(A) tail (20) . The calculated molecular weight of the predicted 290-amino-acid polypeptide is 31,169. Only one potential N-linked glycosylation site was found, at predicted amino acid position 214 (Fig. 4) . Upon hydropathy analysis, the carboxy-terminal end of the predicted polypeptide was found to contain two hydrophobic potential transmembrane domains (data not shown). No signal peptide was found. As determined by GenBank protein homology analysis, the predicted 290-amino-acid sequence lacks any significant homology to any other known protein sequences, including those of other herpesviruses and oncoproteins.
Generation of fusion proteins and production of antibodies against them. The locations of the potential epitopes predicted from the antigenicity plot are presented in Fig. 5A .
Five DNA fragments (Fig. SB, fragments 1, 2, 3, 4, and 5) from the pp38 ORF coding region were cloned into various pATH vectors, and five respective trpE fusion proteins were generated (Fig. 5C, lanes 1, 2, 3, 4, and 5) . Because of the initial low expression of the fragment 3 fusion protein (Fig.  SC, lane 3) , an additional fusion protein of fragment 3 was produced (Fig. SC, lane 3A) . Antibodies against these six fusion proteins were produced in rabbits as described in Materials and Methods, and the sera were designated antisera 1, 2, 3, 3A, 4, and 5, respectively.
Identification of pp38 as the only gene product of the pp38 ORF. Immunoprecipitation analysis of culture media and lysates from mock-and MDV-infected DEF cells was done with all six antisera produced against the pp38 ORF trpE fusion proteins. No MDV-specific protein was immunoprecipitated from the culture media by the six antisera (data not shown). However, one predominant 38-kDa protein (designated pp38 on the basis of phosphorylation analysis; see below) and a minor 24-kDa protein (designated p24) were found in immunoprecipitates from MDV-infected cell lysates by five of the six antisera (Fig. 6, lanes 1, 3, 3A, 4 , and 5).
The antiserum against the fragment 2 fusion protein (Fig. 6 , lane 2) was negative for these two proteins, supporting the prediction by the Hopp-Woods program (12) that a major portion of fragment 2 is poorly antigenic (Fig. SA) . Antibody titration analysis indicated that antiserum S contained the highest antibody titer among the five positive antisera (data not shown). Therefore, only antiserum 5, designated antipp38 hereafter, was used in the subsequent immunoprecipitations.
Pulse-chase labeling analysis was performed to determine whether there was any precursor-product relationship between pp38 and p24. Both mock-and MDV-infected DEF cells were pulse-labeled for 15 min and chased for 0, 5, and 15 min. Lysates from labeled cells were subjected to immunoprecipitation analysis with anti-pp38 (Fig. 7A) . There seemed to be no apparent relationship between pp38 and p24. pp38 was partly degraded during the first 5 min of the chase and then remained stable. However, no concomitant increase in p24 was observed. Similar results were obtained when 5 min of pulse-labeling along with chases for 0, 5, 15, and 30 min were used (data not shown). Western blot analysis was conducted to determine whether both pp38 and p24 are protein products of the pp38 ORF. Only pp38 was observed in MDV-infected cell lysates when the nitrocellulose filter was probed with anti-pp38 (Fig.  7B, lane INF) . As determined by autoradiographic analysis of the filter used for the Western blot, the amount of p24 transferred to the filter was quite substantive (Fig. 7C) . p79, an MDV protein that always tends to be nonspecifically trapped during immunoprecipitation (Fig. 7C) , served as an internal negative control. Despite the abundance of both p24 and p79 on the filter (Fig. 7C) , neither was detected by anti-pp38 on the Western blot (Fig. 7B) .
Characterization of pp38. To determine whether the 38-kDa protein identified in this study is phosphorylated, we immunoprecipitated lysates from 32P-labeled mock-and MDV-infected DEF cells with anti-pp38 (Fig. 8A, lanes 1  and 2) . Lysates from 3"S-labeled mock-and MDV-infected DEF cells were used as controls (Fig. 8A, lanes 3 and 4) . The results of SDS-PAGE analysis showed that pp38 is phosphorylated (Fig. 8A, lane 2 ). An additional phosphorylated protein was found at the 31-kDa position in infected cells (Fig. 8A, lane 2) , but it seems to be a cell protein, since a similar protein was slightly labeled in the control lane (Fig.  8A, lane 1) . There was little, if any, 32P-labeled protein at the 24-kDa position in either control or infected-cell lysates (Fig.   8A, lanes 1 and 2) .
Generally, PAA-insensitive herpesvirus genes tend to encode one of the early classes (IE or early) of herpesvirus proteins (9) . To determine whether the expression of the gene encoding pp38 is sensitive to PAA treatment, we immunoprecipitated lysates from treated and untreated cells with anti-pp38 (Fig. 8B, lanes 5, 6, 7 , and 8). As positive late protein controls (Fig. 8B, lanes 1, 2, 3, and 4) , the corresponding culture media from treated and untreated DEF cells were immunoprecipitated with immune chicken sera (ICS) to determine the amount of gp57-65 (A antigen), an MDV homolog of herpes simplex virus gC which was known to be predominantly present in the media (10) (Fig. 8C, lane 3 ).
To directly demonstrate whether a gene related to the pp38 gene identified in this study is expressed in the latently infected and transformed MSB-1 lymphoblastoid tumor cell line, we performed immunoprecipitation analysis of a lysate froM 35 S-labeled MSB-1 cells (Fig. 8D, cells (Fig. 8D, lanes CON and INF) , with anti-pp38. pp38 was expressed in the MSB-1 tumor cell line in the absence of induction by IUdR (Fig. 8D, lane MSB) .
To determine whether pp38 is an immunogen in birds with MD, we used ICS for immunoprecipitation and SDS-PAGE analysis of lysates from mock-and MDV-infected DEF cells. ICS were found to contain antibodies reactive with pp38 (Fig. 8E, lane 4) . This result was also confirmed by Western blot analysis, in which ICS detected both the trpE-pp38 fusion protein and pp38 in an MDV-infected DEF cell lysate (data not shown).
DISCUSSION
In this study, the use of cDNA analysis to detect the entire gene encoding pp38 was done as part of our laboratory's general MDV gene identification program and, more specifically, resulted from an attempt to further locate the gene encoding the MDV B-antigen complex (gplOO, gp6O, and gp49), which was originally thought to be located in the same region of the genome (32) . This identification of the complete gene encoding pp38 and the subsequent analysis of its nucleotide sequence facilitated many experiments and observations that confirmed and greatly extended our understanding of this important MDV antigen. Of central importance was the ability to prepare a highly specific antibody reactive against pp38 (anti-pp38) by using the gene nucleotide sequence and predicted amino acid sequence data in a fusion protein approach to antibody production. On the basis of the analysis of the pp38 gene nucleotide sequence data and the single protein truly immunoprecipitable by antipp38, the following points can be summarized. Despite the early reports of multiple phosphoproteins immunoprecipitable with monoclonal (6, 13, 22, 31) and polyclonal (6) antibodies, it appears from this study that pp38 is the primary gene product. Furthermore, it appears that p24 is not a processing or degradation product of pp38. Through the use of anti-pp38, it was possible to determine that the product of the gene described in this study is phosphorylated, serotype 1 specific (with respect to serotype 3), and expressed both in lytically infected fibroblast cells and in latently infected and transformed lymphoblastoid tumor cells, thereby confirming the previously reported properties of pp38 (13, 31) from a gene-based perspective. Also, this is the first report that pp38 is an immunogen in birds with MD. Finally, by precisely locating the complete gene encoding pp38, it was possible to determine that the gene encoding the B-antigen complex is not located in the same region of the genome, as was previously thought to be the case. When appropriate, the points summarized above will be discussed in more depth below to further contribute to our understanding of the molecular biology of MDV.
To ensure that pp38 identified in this study is the same as the 38-kDa phosphoprotein reported by others (6, 13, 31), we characterized the properties of pp38. Most of the properties of pp38 described here, such as its phosphorylation and failure to be detected in HVT-infected cells, are identical to those of the 38-kDa phosphoprotein, suggesting that these proteins are the same. The approach used to identify the gene encoding pp38 in this study was based on finding the ORF first and then determining its product, an approach entirely different from that of Cui et al. (6) . In addition, nucleotide sequence analysis of the complete gene found by their approach (18a) resulted in an ORF nucleotide sequence identical to that of the pp38 ORF reported here.
The term pp38 used in this study is derived from that which was first used by Cui et al. (6) and which was apparently based on the original discovery of a 38-kDa polypeptide as one of a group of three (31) and is consistent with the proposed MDV protein nomenclature (30) . Furthermore, the size estimate of 38 kDa in this study (Fig. 6 ) is in full agreement with the published size (6, 31). Nakajima et al. (22) used the term pp39/36, possibly as an extension of their earlier report of four polypeptides (13) . However, the band more recently identified as pp39/36 (22) seems to be a single polypeptide, not a doublet, and most likely is the pp38 described by Cui et al. (6) and in the present report. Of importance are the observations that pp38 (pp39/36) is always the most prominent (8-to 10-fold more) polypeptide of the group of phosphoproteins (6, 13, 22, 31) and that a larger polypeptide (41 or 43 kDa) was not detected in this study. The protein data of this study (discussed in more depth below) all point to pp38 as the sole phosphoprotein among the groups reported by others. Identification and sequence analysis of the gene encoding pp38 in this study provide further support for continuing the present nomenclature and are expected to provide clarity as MDV protein nomenclature evolves to accommodate gene identification (30) .
The facts that pp38 is expressed in the MSB-1 lymphoblastoid tumor cell line (Fig. 8D ) and tumor lesions of MDV-infected chickens (21) and that convalescent-phase sera from chickens with MD are capable of immunoprecipitating pp38 from MDV-infected DEF cells (Fig. 8E, lane 4) fulfill the early criteria for a tumor antigen, as originally set forth for polyomavirus large T antigen (11) . Therefore, on the basis of these criteria, pp38 can appropriately also be referred to as an MDV tumor antigen. Later, the polyomavirus large T antigen was found to be an oncogene (9). Nakajima et al. (22) suggested that the group of phosphoproteins may be associated with MDV oncogenicity. However, on the basis of the protein sequence homology analysis in this study, there is no significant homology between the predicted amino acid sequence of the pp38 gene and that of any known oncogene. In addition, pp38 was not found to be a nuclear DNA binding protein (18a) , although that is not a universal requirement for an oncogene. Silva and Lee (31) reported that the 38-kDa protein was detected in cells infected with the attenuated, avirulent serotype 1 Mdll/75c MDV strain. Thus, if pp38 plays a role in MDV transformation, two possibilities exist: (i) it is modified during attenuation or (ii) it is necessary but insufficient and indirect, and attenuation involves another gene(s). Whether pp38 is a unique MDV oncogene remains to be determined.
On the basis of their initial analysis of Agtll clones, Cui et al. (6) suggested that duplicate copies of the pp38 gene may exist in BamHI-D and -H, which contain MDV long terminal repeat (TRL) and long internal repeat (IRL) sequences, respectively. Since the 5' end of the pp38 ORF identified in this study is located in IRL, duplication of this part of the ORF in TRL was considered a possibility. A (6) reported that pp38 and four other proteins ly been identified, (135, 41, 24, and 20 kDa) were immunoprecipitated by )V homolog of the antisera against two MDV-lacZ fusion proteins. Since the ly reported to be pp38 gene reported here is located in the same region (Fig. 1 ) al. (26) , encodes as their two Xgtll clones (6), it is possible that the four other previously identiproteins are not encoded in that region of BamHI-H. Since the lacZ system was used in their study (6) , as opposed to script for the pp38 the trpE system that was in this study, it is possible that and the EcoRI c antibodies against the epitopes of the larger lacZ protein 2A and B). Concross-react with some viral proteins. However, it is more is usually present likely that the four other proteins were nonspecifically anscript identified trapped during immunoprecipitation. The fact that pp38 gene expression is relatively insensitive to PAA treatment suggests that pp38 could be one of the early classes of herpesvirus proteins. Furthermore, such an interpretation of the data is consistent with a previous report (29) which showed that an unidentified 1.9-kb IE gene transcript was detected in BamHI-H. While the precise location of this unidentified IE gene remains to be clarified in relation to the location of the pp38 gene, the distinct possibility exists that these genes are the same. Many IE genes in other herpesviruses tend to regulate early or late gene expression (9) . However, since the amount of pp38 was partially reduced when PAA was used, it is also possible that the gene encoding pp38 is a leaky late gene. Whether the pp38 gene is actually an IE, early, or leaky late gene and whether it has a regulatory function remain to be determined.
ICS were found to contain antibodies capable of immunoprecipitating pp38 (Fig. 8E, lane 4) , indicating that pp38 is an immunogen in birds with MD. This result is different form that previously reported (31) . ICS also contain antibodies against the B-antigen complex (16) which were found to elicit virus neutralization (15) and immunoprotection against MDV (24) . Whether pp38, as an immunogen in birds with MD, is capable of eliciting virus neutralization and immunoprotection against MDV remains to be determined. The finding in this study that pp38 is expressed in the MSB-1 cell line confirms previous observations (6, 13) . However, IUdR, a drug known to enhance overall gene expression in the latently infected MSB-1 lymphoblastoid tumor cell line (8) , was used in the previous studies (6, 13) to detect pp38, implying that pp38 is not readily expressed in the latency stage. In this study, no IUdR was used and an abundant level of pp38 was expressed and detected in the latently infected MSB-1 lymphoblastoid tumor cell line (Fig.  8D) . The fact that pp38 is abundantly expressed in a constitutive manner not only in lytically infected fibroblast cells but also in latently infected MSB-1 lymphoblastoid tumor cells suggests that it may play a role in the establishment and maintenance of latency.
